Australia's EchoIQ rises on commercial licensing deal

Vitasora Health

25/01/2024 24:37

** Shares of EchoIQ Ltd  EIQ.AX  up 3.7% at A$0.14, set for
best day since Jan 17, if gains hold 
    ** Medical technology firm says it entered into a commercial
licensing agreement with Respiri Ltd  RSH.AX  
    ** Says agreement to apply co's AI-backed EchoSolv
cardiovascular solutions to Respiri's remote patient monitoring
user base
    ** EchoIQ stock down 20.6% YTD, as of last close

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))